Those on a 9 mg dose lost 45.4 lb, about 19.1 percent of starting weight
In Phase 2 studies, participants taking higher doses of retatrutide lost an average of up to 24% of their body weight over 48 weeks
On any given week that means neighbors from Whiskey Creek and Pelican Preserve, Cape patients out of Sandoval and Pelican, Bonita regulars from Spanish Wells, Waterway Estates residents from North Fort Myers, and beach folks from Bowditch Point
Notably, the $500 range is also the amount manufacturers offer for self-pay obesity patients, raising important questions about whether these programs are truly benefiting those who need them most 5,6
Based on receptor profile and emerging research trends: For appetite suppression alone GLP-1 agonists are effective For enhanced incretin signalling Tirzepatide expands the pathway For multi-pathway metabolic modulation Retatrutide currently appears the most comprehensive Secretagogues may support lean mass preservation
Exendin-4, a glucagon-like peptide-1 receptor agonist, provides neuroprotection in mice transient focal cerebral ischemia